A clinical perspective of venous thromboembolism.
Moll
Stephan
S
University of North Carolina School of Medicine, Department of Medicine, Division of Hematology-Oncology, Chapel Hill NC 27599-7035, USA. smoll@med.unc.edu
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004417:Dyspnea / Q000175:diagnosis / Q000209:etiology; D004636:Emergency Service, Hospital; D005260:Female; D005500:Follow-Up Studies; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D008134:Long-Term Care; D008279:Magnetic Resonance Imaging; D010690:Phlebography; D011186:Postphlebitic Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D012008:Recurrence; D019233:Retreatment; D012720:Severity of Illness Index; D015912:Thrombolytic Therapy / Q000379:methods; D013997:Time Factors; D018608:Ultrasonography, Doppler; D054556:Venous Thromboembolism / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight